Lincoln National Corp Jazz Pharmaceuticals PLC Transaction History

Lincoln National Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 08, 2018	SELL	$146.33 - $183.18 $310,512 - $388,707	-2,122 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$135.59 - $157.16 $287,721 - $333,493	-2,122 Reduced 50.0%	2,122 $321,000
Q4 2017 Feb 13, 2018	BUY	$131.06 - $150.39 $278,109 - $319,127	2,122 Added 100.0%	4,244 $571,000
Q3 2017 Oct 31, 2017	SELL	$142.62 - $155.6 $21,393 - $23,340	-150 Reduced 6.6%	2,122 $311,000
Q2 2017 Aug 07, 2017	BUY	N/A	2,272	2,272 $353,000

513

57.7M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.53B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.